When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Karyopharm down 40% on Ad Com briefing docs for selinexor
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics (KPTI-39.5%) is down on a 6x surge in volume following the release of briefing materials for next Tuesday's FDA advisory committee meeting on selinexor tablets (with dexamethasone) in relapsed/refractory multiple myeloma (RRMM). The review team does not appear to be on board with the application. Highlights:
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news, Stocks on the move,